Sensitive determination of tilmicosin, erythromycin ethylsuccinate and clindamycin by CE with electrochemiluminescence detection using azithromycin as internal standard and its applications.

A sensitive approach for the simultaneous determination of tilmicosin, erythromycin ethylsuccinate and clindamycin was developed by CE coupled with electrochemiluminescence detection with ionic liquid. The parameters for CE, electrochemiluminescence detection and the effect of ionic liquid were investigated systematically. The three analytes were well separated and detected within 8 min. The limits of detection (S/N=3) of tilmicosin, erythromycin ethylsuccinate and clindamycin are 3.4x10(-9), 2.3x10(-8) and 1.3x10(-8) mol/L, respectively. The precisions (RSD%) of the peak area and the migration time are from 0.8 to 1.5% and from 0.2 to 0.5% within a day and from 1.8 to 2.7% and from 0.6 to 0.8% in 3 days, respectively. The limits of quantitation (S/N=10) of tilmicosin, erythromycin ethylsuccinate and clindamycin are 3.2x10(-8), 2.9x10(-7) and 9.1x10(-8) mol/L in human urines and 5.5x10(-8), 3.2x10(-7) and 2.1x10(-7) mol/L in milk samples, respectively. The recoveries of three analytes at different concentration levels in urine, milk and drugs are between 90.0 and 104.7%. The proposed method was successfully applied to the determination of three analytes in human urine, milk and drugs.

Nondestructive quantitative analysis of erythromycin ethylsuccinate powder drug via short-wave near-infrared spectroscopy combined with radial basis function neural networks.

A new assay method for the nondestructive determination of erythromycin ethylsuccinate powder drug via short-wave near-infrared spectroscopy (NIR) combined with radial basis function (RBF) neural networks is investigated. The modern near-infrared spectroscopy analysis technique is efficient, simple and nondestructive, which has been used in chemical analysis in diverse fields. Short-wave NIR is a more rapid, flexible, and cost-effective method to control product concentration in pharmaceutical industry. The RBF neural networks are local approximation networks that have superiorities in function approximation and learning speed. In addition, the structure of RBF networks is simple. Estimate and calibration of the sample concentration via short-wave NIR are made with the aid of RBF models based on conventional spectra, standard normal variate (SNV), multiplicative scatter correction (MSC) and the first-derivative spectra. Various optimum models of them are established and compared. Experiment results show that the models of SNV spectra can give better performance, and the optimized RBF neural network model after SNV treatment were given, by which the root-mean-square-errors (RMSE) for calibration set and test set were 0.3266% and 0.5244%, respectively and the correlation coefficients (R) for calibration set and test set were 0.9942 and 0.9852, respectively. The proposed RBF method based on short-wave NIR is more valuable and economical for quantitative analysis than traditional methods such as partial least squares (PLS).

A validated spectrofluorometric assay for the determination of certain macrolide antibiotics in pharmaceutical formulations and spiked biological fluids.

This paper describes a simple spectrofluorometric method for the analysis of 4 macrolide antibiotics. The method is based on the condensation of 10% (w/v) malonic acid and acetic acid anhydride under the catalytic effect of tertiary amine groups of the studied macrolides. The relative fluorescence intensity of the condensation product was measured at 397/452 nm (excitation/emission) for azithromycin dihydrate and at 392/445 nm (for clarithromycin, erythromycin ethylsuccinate, and roxithromycin. All variables affecting the reaction conditions were studied. The effects of potential interference due to common excipients, such as starch, lactose, sucrose, glucose, gum acacia, and magnesium stearate, as well as trimethoprim and sulfisoxazole acetyl formulated in primomycin capsules and pediazole oral suspension, respectively, were studied. A validation study for the proposed method was carried out according to U.S. Pharmacopeia 2002. The linearity ranges were 3-80 ng/mL for all of the cited macrolides. The limit of detection range was 0.74-1.20 ng/mL, while the limit of quantitation range was 2.47-4.02 ng/mL. The method was applied for the assay of the studied macrolides in pure pharmaceutical formulations and in spiked biological fluids. Results were compared with those obtained from the reported method, where calculated t- and F-values indicated high accuracy and good precision for the proposed method.

Construction of universal quantitative models for determination of roxithromycin and erythromycin ethylsuccinate in tablets from different manufacturers using near infrared reflectance spectroscopy.

Universal quantitative models using NIR reflectance spectroscopy were developed for the analysis of API contents (active pharmaceutical ingredient) in roxithromycin and erythromycin ethylsuccinate tablets from different manufacturers in China. The two quantitative models were built from 78 batches of roxithromycin samples from 18 different manufacturers with the API content range from 19.5% to 73.9%, and 66 batches erythromycin ethylsuccinate tablets from 36 manufacturers with the API content range from 28.1% to 70.9%. Three different spectrometers were used for model construction in order to have robust and universal models. The root mean square errors of cross validation (RMSECV) and the root mean square errors of prediction (RMSEP) of the model for roxithromycin tablets were 1.84% and 1.45%, respectively. The values of RMSECV and RMSEP of the model for erythromycin ethylsuccinate tablets were 2.31% and 2.16%, respectively. Based on the ICH guidelines and characteristics of NIR spectroscopy, the quantitative models were then evaluated in terms of specificity, linearity, accuracy, precision, robustness and model transferability. Our study has shown that it is feasible to build a universal quantitative model for quick analysis of pharmaceutical products from different manufacturers. Therefore, the NIR method could be used as an effective method for quick, non-destructive inspection of medicines in the distribution channels or open market.

Selective spectrophotometric method for the determination of erythromycin and its esters in pharmaceutical formulations using gentiana violet.

A simple and selective method for the determination of erythromycin and its stearate and succinate esters in their pure forms and in pharmaceutical formulations is described. The procedure is based on the formation of a blue-coloured (lambda max = 633 nm) complex with gentiana violet in alkaline medium. Different variables affecting the colour development were studied and optimized. The method was used to determine 2.5-25 micrograms ml-1 of erythromycin in the final measured solution. The simplicity of the method permits rapid analysis and it is thus suitable for routine control. The method is highly specific for the determination of stearate and succinate esters in pharmaceutical formulations. The reliability of the method was established by parallel determinations against the official British Pharmacopoeial method.

Determination of erythromycin ethylsuccinate by liquid chromatography.

A method is described for the determination of erythromycin ethylsuccinate by liquid chromatography. A C18 reversed-phase column (25 cm x 4.6 mm I.D.) was used with acetonitrile-0.2 M tetrabutylammonium sulphate (pH 6.5)-0.2 M phosphate buffer (pH 6.5)-water [x:5:5:(90-x)] as mobile phase. The proportion of acetonitrile (x) has to be adapted to the type of stationary phase used. For RSil C18 LL, 42.5% was used. The column was heated at 35 degrees C, the flow-rate was 1.5 ml/min and UV detection was performed at 215 nm. The main component, erythromycin A ethylsuccinate, was separated from all other components which were present in commercial samples. The main impurities were erythromycin A and the ethylsuccinate esters of erythromycin B and C. The amide N-ethylsuccinyl-N-demethylerythromycin A was shown to be present in all the samples examined. The method was successfully applied to the analysis of specialities.

[Photometric determination of monomycin in biological materials]. / Fotometricheskoe opredelenie monomitsina v biologicheskikh materialakh.

A photometric procedure for determination of monomycin in biological materials, such as blood, milk, urine was developed on the basis of the investigation of the reaction of monomycin complex formation with phthalexon-S and praseodymium in water-ethanol medium (1 : 1). The error of estimation of 0.1 microgram of monomycin in 1 ml of a biological material did not exceed 5 per cent (rel.).

[Some patterns in the distribution of free and bound monomycin in the organs and tissues of immunized animals]. / Nekotorye zakonomernosti raspredeleniia svobodnogo i sviazannogo monomitsina v organakh i tkaniakh immunizirovannykh zhivotnykh

Distribution of unbound and bound monomycin in rabbits immunized against paratyphoid fever and colibacteriosis was studied at various stages of the immunization. The studies showed that the immunological reconstruction had a definite effect on the distribution character and the processes of the antibiotic binding in the vaccinized rabbits. The binding processes in the lymphoid cells increased, while those in the parenchimatose cells decreased. The concentration of the unbound and bound preparation in the organs and tissues at the background of the immunity was 2-3 times lower than that in the non-immunized animals. The bone marrow, where it markedly increased was an exception.